Using a conditional knockout model, we observed that NRF2 deletion in KRAS-mutant pancreatic epithelium led to a marked increase in IPMN-like lesions despite suppressing PanIN formation. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.